Nykode Therapeutics AS

OTCPK:VACB.F Stock Report

Market Cap: US$87.8m

Nykode Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:VACB.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
27 Mar 25BuyUS$611,391Norda ASACompany3,000,000US$0.20
20 Dec 24BuyUS$26,371Caaby ASCompany100,000US$0.26
20 Dec 24SellUS$26,371Christian ÅbyholmIndividual100,000US$0.26
08 Nov 24BuyUS$870,160Norda ASACompany5,000,000US$0.17
08 Nov 24BuyUS$870,160Norda ASACompany5,000,000US$0.17
21 Aug 24BuyUS$26,934Alf Gunnar NicklassonIndividual50,000US$0.54

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of VACB.F?
Owner TypeNumber of SharesOwnership Percentage
Public Companies15,996,7554.9%
VC/PE Firms26,000,0007.96%
General Public49,584,13915.2%
Individual Insiders52,115,21116%
Private Companies82,621,17125.3%
Institutions100,229,16830.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 78.51% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.6%
Jan Haudemann-Andersen
41,189,050US$11.1m0%no data
9.24%
Rasmussengruppen AS
30,180,750US$8.1m0%11.09%
7.96%
Datum Opportunity As
26,000,000US$7.0m0%no data
5.42%
Victoria India Fund AS
17,705,175US$4.8m0%no data
4.9%
Norda ASA
15,996,755US$4.3m23.1%no data
4.61%
State Street Global Advisors, Inc.
15,059,261US$4.0m-4.8%no data
4.61%
Capital Research and Management Company
15,050,000US$4.0m0%no data
3.85%
Datum Invest AS
12,560,250US$3.4m0%no data
3.23%
Joh Johannson Eiendom AS
10,561,631US$2.8m0%no data
3.16%
RADFORSK
10,315,311US$2.8m-42.1%43.68%
2.29%
Vatne Capital AS
7,485,857US$2.0m0%no data
2%
Om Holding AS
6,519,525US$1.8m0%no data
1.94%
Handelsbanken Asset Management
6,331,396US$1.7m0%no data
1.52%
Simen Thorsen
4,950,000US$1.3m0%no data
1.38%
Portia AS
4,500,000US$1.2m0%no data
1.37%
Krag Invest As
4,470,100US$1.2m0%no data
1.07%
Alden AS
3,498,445US$940.3k-10.3%no data
1.06%
JPMorgan Chase & Co, Brokerage and Securities Investments
3,471,645US$933.1k0%no data
1.03%
AS Kassiopeia
3,365,000US$904.5k0%no data
0.94%
KLP Kapitalforvaltning AS
3,061,555US$822.9k-1.27%no data
0.92%
Borgano AS
3,000,000US$806.4k0%no data
0.87%
Tore Voldberg
2,850,000US$766.1k0%no data
0.87%
Danske Invest Asset Management AS
2,828,203US$760.2k-8.12%0.42%
0.84%
Swedbank Asset Management AS SMB
2,753,846US$740.2k-12.7%0.8%
0.82%
Danske Capital AB
2,682,839US$721.1k-11.8%0.06%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/14 21:43
End of Day Share Price 2025/04/23 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nykode Therapeutics AS is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Viktor SundbergABG Sundal Collier Sponsored
Geir HolomDNB Markets
Lucy-Emma Mary Codrington-BartlettJefferies LLC